| π Article Summary β Health Monitoring Schedules for Hazardous Substances | |
|---|---|
| Entity | Anitech Group β Occupational Hygiene |
| Article Type | Regulatory Reference / Compliance Schedule |
| Target Audience | WHS managers, HR directors, occupational health nurses, EHS professionals |
| Key Entities | Safe Work Australia, model WHS Regulations Part 7.1, Schedule 14, state WHS regulators, occupational physicians |
| Regulations & Standards | Model WHS Regulations Schedule 14 β hazardous chemicals requiring health monitoring; regulation 435 β duty to provide health monitoring; regulation 444 β records retention 30 years |
| Key Fact 1 | Schedule 14 of the model WHS Regulations specifies 16 chemical groups requiring mandatory health monitoring β including lead, mercury, organophosphate pesticides, isocyanates, and crystalline silica. |
| Key Fact 2 | Health monitoring records must be retained for 30 years under regulation 444 β reflecting the long latency of occupational disease and the need for retrospective exposure-outcome investigation. |
| Key Fact 3 | The duty to provide health monitoring triggers when a worker is carrying out ongoing work and there is a significant risk β not when disease is already confirmed. Prevention, not reaction, is the intent. |
| What This Covers | Complete Schedule 14 chemical list, monitoring triggers and frequency, specific test requirements by substance, medical practitioner requirements, reporting to regulator and worker |
| What This Does Not Cover | Non-Schedule 14 hazardous substances (assessed under general duty), biological monitoring vs health monitoring distinction |
| Primary CTA | Contact Anitech to design and coordinate a compliant health monitoring programme for your workers |
| Read Time | 10 min read |
Health Monitoring Schedules: What Hazardous Substances Require Health Monitoring in Australia
Under the model Work Health and Safety Regulations (Part 7.1 Subdivision 3 and Schedule 14), certain hazardous chemicals create a mandatory duty for PCBUs to provide health monitoring to workers carrying out ongoing work involving significant exposure. This is not a best-practice recommendation β it is a legal obligation, non-compliance with which may constitute a regulatory breach with significant penalties.
The Legislative Trigger for Health Monitoring
Regulation 435 specifies that a PCBU must ensure health monitoring is provided to a worker if:
- The worker is carrying out ongoing work using, handling, generating or storing a hazardous chemical listed in Schedule 14; AND
- There is a significant risk to the worker’s health because of exposure to that chemical
“Significant risk” is determined by considering: the nature and severity of the health effect; the likelihood of exposure causing the health effect; and whether the health effect can be detected before it causes irreversible harm. A risk assessment β including air or biological monitoring where appropriate β supports the “significant risk” determination.
Schedule 14 Hazardous Chemicals Requiring Health Monitoring
The following chemical groups trigger mandatory health monitoring obligations under Schedule 14 (summarised; refer to the full regulation for complete requirements):
| Chemical / Group | Key Health Monitoring Tests | Typical Frequency |
|---|---|---|
| Acrylonitrile | Medical and exposure history; biological monitoring (urinary metabolites) | 6-monthly |
| Arsenic (inorganic) | Urinary inorganic arsenic; clinical examination | Annually or 6-monthly (high exposure) |
| Asbestos (all types) | Chest X-ray (PA), spirometry, symptom review | Every 2 years |
| Benzene | Blood count (CBC), urinary trans,trans-muconic acid; clinical examination | Annually or 6-monthly |
| Cadmium | Blood cadmium; urinary cadmium, beta-2-microglobulin; clinical examination | Annually |
| Chromium (hexavalent) | Urinary chromium; nasal and skin examination; chest X-ray if significant exposure | Annually |
| Crystalline silica (RCS) | Chest X-ray (ILO B-reader), spirometry; symptom questionnaire | 1β5 years (risk-based) |
| Isocyanates | Respiratory function tests (spirometry, FeNO); specific IgE testing if indicated | 6-monthly in first year; annually thereafter |
| Lead (inorganic) | Blood lead (BPb); ZPP or FEP; clinical examination | 3-monthly (BPb <10 Β΅g/dL); more frequently at higher levels |
| Mercury (inorganic) | Urinary mercury; clinical neurological assessment; urinalysis | Annually |
| Organophosphate pesticides | Plasma cholinesterase; red cell cholinesterase; clinical examination | Before season, during season (at least once), end of season |
| Pentachlorophenol (PCP) | Urinary PCP; clinical examination | 6-monthly or exposure-triggered |
| Thallium | Urinary thallium; clinical examination | Annually or exposure-triggered |
| Vinyl chloride monomer | Liver function tests; liver ultrasound; clinical examination | Annually |
Lead Health Monitoring in Detail
Lead is one of the most common Schedule 14 triggers in Australian manufacturing, recycling, mining and construction. Blood lead concentration (BPb in Β΅g/dL) is the primary biological monitoring measure. The model WHS Regulations specify action and removal levels:
- BPb β₯10 Β΅g/dL: Review exposure controls and re-test within 3 months
- BPb β₯15 Β΅g/dL (males) or β₯10 Β΅g/dL (females of reproductive age): Review controls; physician assessment; more frequent monitoring
- BPb β₯30 Β΅g/dL (males) or β₯20 Β΅g/dL (females of reproductive age): Removal from lead exposure until BPb falls; physician review for return to work
Lead monitoring must be conducted by or supervised by a registered medical practitioner. Results must be provided to the worker within 5 working days of receipt from the laboratory.
Record Keeping and Regulatory Notification
Health monitoring records must be kept for 30 years (model WHS Regulations regulation 444). Records must be kept confidential β the PCBU may not share individual results without the worker’s consent, except in defined circumstances (regulatory notification of specified findings).
The PCBU must notify the regulator if any health monitoring result indicates a work-related disease or condition β for example, a confirmed diagnosis of lead poisoning, silicosis, or asbestosis. Notification timelines are specified in WHS regulations and typically require urgent reporting for serious diagnoses.